Adaptive Biotechnologies shareholder plans 11K sale
ADPT filed a Form 144 disclosing proposed sales of equity tied to prior awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ADPT filed a Form 144 disclosing proposed sales of equity tied to prior awards. The filing lists 10,000 shares from previously exercised stock options dated 01/25/2022 and 1,000 restricted stock units dated 03/04/2022. The filing also reports 41,338 shares sold during the past three months for $544,421.46. The report identifies Morgan Stanley Smith Barney LLC as the broker-dealer and provides an address for the reporting person, Susan Bobulsky.
Insights
Form 144 lists proposed resale of award-derived shares via a broker-dealer.
The filing shows 10,000 shares from previously exercised options (01/25/2022) and 1,000 RSUs (03/04/2022), with a broker-dealer named as the intermediary. The sale method is consistent with routine resale reporting requirements.
Cash-flow treatment and exact timing of transactions are not specified in the excerpt; subsequent filings or trade reports would show executed sales and purchaser details.
AI-generated analysis. How Rhea-AI works. Not financial advice.